-
1
-
-
84875804295
-
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
-
Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374-403.
-
(2013)
Eur J Cancer
, vol.49
, pp. 1374-1403
-
-
Ferlay, J.1
Steliarova-Foucher, E.2
Lortet-Tieulent, J.3
Rosso, S.4
Coebergh, J.W.5
Comber, H.6
-
2
-
-
79955006086
-
Lung cancer: New biological insights and recent therapeutic advances
-
Ramalingam SS, Owonikoko TK, Khuri FR. Lung cancer: New biological insights and recent therapeutic advances. CA Cancer J Clin. 2011;61:91-112.
-
(2011)
CA Cancer J Clin
, vol.61
, pp. 91-112
-
-
Ramalingam, S.S.1
Owonikoko, T.K.2
Khuri, F.R.3
-
3
-
-
34248326881
-
The cost of lung cancer in Alberta
-
Demeter S, Jacobs P, Chmielowiec C, Logus W, Hailey D, Fassbender K, et al. The cost of lung cancer in Alberta. Can Respir J. 2007;14:81-6.
-
(2007)
Can Respir J
, vol.14
, pp. 81-86
-
-
Demeter, S.1
Jacobs, P.2
Chmielowiec, C.3
Logus, W.4
Hailey, D.5
Fassbender, K.6
-
4
-
-
2942603001
-
Management and costs of treating lung cancer patients in a university hospital
-
Dedes KJ, Szucs TD, Bodis S, Joerger M, Lowy A, Russi EW, et al. Management and costs of treating lung cancer patients in a university hospital. Pharmacoeconomics. 2004;22:435-44.
-
(2004)
Pharmacoeconomics
, vol.22
, pp. 435-444
-
-
Dedes, K.J.1
Szucs, T.D.2
Bodis, S.3
Joerger, M.4
Lowy, A.5
Russi, E.W.6
-
5
-
-
82255169622
-
Treatment patterns, use of resources, and costs of advanced non-small-cell lung cancer patients in Spain: Results from a Delphi panel
-
Isla D, González-Rojas N, Nieves D, Brosa M, Finnern HW. Treatment patterns, use of resources, and costs of advanced non-small-cell lung cancer patients in Spain: results from a Delphi panel. Clin Transl Oncol. 2011;13:460-71.
-
(2011)
Clin Transl Oncol
, vol.13
, pp. 460-471
-
-
Isla, D.1
González-Rojas, N.2
Nieves, D.3
Brosa, M.4
Finnern, H.W.5
-
6
-
-
78751647585
-
How affordable are targeted therapies in non-small cell lung cancer?
-
Coate LE, Leighl NB. How affordable are targeted therapies in non-small cell lung cancer? Curr Treat Options Oncol. 2011;12:1-11.
-
(2011)
Curr Treat Options Oncol
, vol.12
, pp. 1-11
-
-
Coate, L.E.1
Leighl, N.B.2
-
7
-
-
0038352089
-
Direct treatment costs for patients with lung cancer from first recurrence to death in France
-
Braud AC, Levy-Piedbois C, Piedbois P, Piedbois Y, Livartovski A, Le Vu B, et al. Direct treatment costs for patients with lung cancer from first recurrence to death in France. Pharmacoeconomics. 2003;21:671-9.
-
(2003)
Pharmacoeconomics
, vol.21
, pp. 671-679
-
-
Braud, A.C.1
Levy-Piedbois, C.2
Piedbois, P.3
Piedbois, Y.4
Livartovski, A.5
Le Vu, B.6
-
8
-
-
14644396447
-
Chemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: Evidence from surveillance, epidemiology and end results-Medicare
-
Ramsey SD, Howlader N, Etzioni RD, Donato B. Chemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: evidence from surveillance, epidemiology and end results-Medicare. J Clin Oncol. 2004;22:4971-8.
-
(2004)
J Clin Oncol
, vol.22
, pp. 4971-4978
-
-
Ramsey, S.D.1
Howlader, N.2
Etzioni, R.D.3
Donato, B.4
-
9
-
-
61549111592
-
Direct costs associated with the disease management of patients with unresectable advanced non-small-cell lung cancer in the Netherlands
-
Pompen M, Gok M, Novák A, van Wuijtswinkel R, Biesma B, Schramel F, et al. Direct costs associated with the disease management of patients with unresectable advanced non-small-cell lung cancer in The Netherlands. Lung Cancer. 2009;64:110-6.
-
(2009)
Lung Cancer
, vol.64
, pp. 110-116
-
-
Pompen, M.1
Gok, M.2
Novák, A.3
Van Wuijtswinkel, R.4
Biesma, B.5
Schramel, F.6
-
10
-
-
81055127613
-
Healthcare costs in patients with metastatic lung cancer receiving chemotherapy
-
Vera-Llonch M, Weycker D, Glass A, Gao S, Borker R, Barber B, et al. Healthcare costs in patients with metastatic lung cancer receiving chemotherapy. BMC Health Serv Res. 2011;11:305.
-
(2011)
BMC Health Serv Res
, vol.11
, pp. 305
-
-
Vera-Llonch, M.1
Weycker, D.2
Glass, A.3
Gao, S.4
Borker, R.5
Barber, B.6
-
11
-
-
33845492124
-
Lung cancer diagnosis: Hospitalisation costs
-
Abal Arca J, Blanco Ramos MA. García de la Infanta R, Pérez López C, González Pérez L, Lamela López J: Lung cancer diagnosis: hospitalisation costs. Arch Bronconeumol. 2006;42:569-74.
-
(2006)
Arch Bronconeumol
, vol.42
, pp. 569-574
-
-
Abal Arca, J.1
Blanco Ramos, M.A.2
García De La Infanta, R.3
Pérez López, C.4
González Pérez, L.5
Lamela López, J.6
-
12
-
-
38349074059
-
Factors influencing hospital costs of lung cancer patients in Northern Ireland
-
Fleming I, Monaghan P, Gavin A, O'Neill C. Factors influencing hospital costs of lung cancer patients in Northern Ireland. Eur J Heal Econ. 2008;9:79-86.
-
(2008)
Eur J Heal Econ
, vol.9
, pp. 79-86
-
-
Fleming, I.1
Monaghan, P.2
Gavin, A.3
O'Neill, C.4
-
15
-
-
84928039544
-
-
RECH Group, Barcelona. Accessed 28 Mar 2014
-
Spanish Network of Hospital Costs Database (RECH). RECH Group, Barcelona. 2010. http://www.rechosp.org. Accessed 28 Mar 2014
-
(2010)
-
-
-
16
-
-
84928039543
-
-
Spanish Ministry of Health. Registry of the Spanish Network of Hospital Costs Database (RECH). (in Spanish). Accessed 9 Dec 2014
-
Spanish Ministry of Health. Statistical Site of the NHS. Registry of the Spanish Network of Hospital Costs Database (RECH). 2014. http://www.msssi.gob.es/estadEstudios/estadisticas/sisInfSanSNS/registros/docs/Resolucion-Reg-BD-RECH-2014.pdf (in Spanish). Accessed 9 Dec 2014.
-
(2014)
Statistical Site of the NHS
-
-
|